Cellectar Biosciences
CLRB
CLRB
40 hedge funds and large institutions have $6.77M invested in Cellectar Biosciences in 2021 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 10 increasing their positions, 5 reducing their positions, and 13 closing their positions.
Holders
40
Holders Change
-6
Holders Change %
-13.04%
% of All Funds
0.7%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
10
Reduced
5
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$535K |
| 2 |
MS
2
Maven Securities
St Helier,
Jersey
|
$935K |
| 3 |
3
Franklin Resources
San Mateo,
California
|
$132K |
| 4 |
4
Bank of New York Mellon
New York
|
$113K |
| 5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$1.82M |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
RCA
51
Ranch Capital Advisors
Sarasota,
Florida
| $0 | 50 | – | – |
|
52
Fidelity Investments
Boston,
Massachusetts
| $0 | 1 | – | – |
|
53
Rockefeller Capital Management
New York
| $0 | 1,000 | – | – |
|
|
AWM
54
AllSquare Wealth Management
Albany,
New York
| $0 | 188 | – | – |
|